On April 4, 2022, in PCMA v. Mulready, the US District Court for the Western District of Oklahoma ruled that the state's Patient's Right to Pharmacy Choice Act (the Act) was not preempted by ERISA and that the state's Insurance Commissioner could enforce it.
In 2019, the state legislature passed the Act to regulate PBMs. The PCMA, a trade organization for PBMs, filed suit against the state the same year, claiming that ERISA preempted the Act because it regulated the nature and scope of a plan'